The RightMed Test is a PGx test that offers comprehensive coverage backed by rigorous curation of high-level, scientific evidence to give providers and their patients confidence in test results. The RightMed Test covers 27 genes that may impact how a patient responds to certain medications used to treat various conditions including psychiatric conditions, cancer, cardiovascular disease, pain, and more.

OneOme, co-founded by Mayo Clinic, is working to help providers incorporate pharmacogenomics into patient care by offering the RightMed Test and associated tools. OneOme’s RightMed solution offers tailored products and services that meet the needs of payers, healthcare organizations, providers, and patients. At the core of the RightMed solution is the RightMed test, which provides genetic information that doctors can use to identify how a patient’s DNA may affect his or her response to hundreds of medications. OneOme pairs the RightMed test with a suite of tools and services including the OneOme portal, no-cost clinical consults with expert PharmDs, training and education, population tools, and more.

2bPrecise delivers transformative point-of-care solutions that serve as the foundation for scalable precision medicine success.

Precision medicine is rewriting the rules of health care. And 2bPrecise is rewriting the rules of precision medicine. Representing decades of deep clinical knowledge and award-winning technology, our 2bPrecise platform heavy-lifts vast amounts of the data you need, then simplifies, condenses and extracts it. The result? Integrated, actionable genomic information delivered directly into your workflow and harmonized with existing patient data – in any EHR. Plus, semantically stored, research-ready data that can be accessed and acted upon for later study – as science evolves. That’s a powerful set of clinical decision-making tools, in your hands – at the point of care.